Nanoparticle light filtering method and apparatus
US-2021103080-A1 · Apr 8, 2021 · US
US11672944B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11672944-B2 |
| Application number | US-202016800951-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 25, 2020 |
| Priority date | Jan 17, 2011 |
| Publication date | Jun 13, 2023 |
| Grant date | Jun 13, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An optical filter may reduce the frequency and/or severity of photophobic responses or for modulating circadian cycles by controlling light exposure to cells in the human eye in certain wavelengths, such as 480 nm and 590 nm, and a visual spectral response of the human eye. The optical filter may disrupt the isomerization of melanopsin in the human eye reducing the availability of the active isoform, whereas the attenuation of light weighted across the action potential spectrum of the active isoform attenuates the phototransduction cascade leading to photophobic responses. Embodiments of an optical filter are described. In one embodiment an optical filter may be configured to transmit less than a first amount of light in certain wavelengths, and to transmit more than a second amount of light weighted across the visual spectral response. Methods of use and methods of manufacturing optical filters are also described.
Opening claim text (preview).
What is claimed is: 1. An apparatus for reducing the frequency and/or severity of photophobic responses or for modulating circadian cycles by controlling exposure of cells in a retina, relative to a visible spectrum range of 400 nm to 700 nm, the apparatus comprising: an optical filter configured to deliver: at most a first dosage of light, averaged across wavelengths between about 565 nm and about 615 nm, said first dosage is D rec,590 ; at most a second dosage of light, averaged across wavelengths between about 454 nm and about 506 nm, wherein said second dosage is D melan ; and at least a third dosage of light, across wavelengths within a visible spectrum between about 506 nm and 565 nm, wherein said third dosage is D grn ; wherein a ratio including said second dosage of light and said third dosage of light is defined as a figure of merit (FOM 1 ), the figure of merit being determined by: FOM 1 = 1 - D melan D melan ( T = 1 ) 1 - D grn D grn ( T = 1 ) where D melan (T=1) is said second dosage of light in the absence of an optical filter, and D grn (T=1) is said third dosage of light in the absence of an optical filter, wherein the figure of merit is at least 1.3, wherein a ratio including said first dosage of light and said third dosage of light is defined as a figure of merit (FOM 2 ), the figure of merit being determined by: FOM 2 = 1 - D rec , 5 9 0 D rec , 5 9 0 ( T = 1 ) 1 - D grn D grn ( T = 1 ) where D rec,590 (T=1) is said first dosage of light in the absence of an optical filter, and D grn (T=1) is said third dosage of light in the absence of an optical filter, wherein the figure of merit is at least 1.3, and wherein the filter has chromaticity coordinates of x=0.33±0.03 and y=0.33±0.03. 2. The apparatus of claim 1 , wherein the figure of merits FOM 1 and FOM 2 are each at least 1.4. 3. The apparatus of claim 1 , wherein the figure of merits FOM 1 and FOM 2 are each at least 1.5. 4. The apparatus of claim 1 , wherein the optical filter includes at least one of a dielectric multi-layer coating, embedded nanoparticle coating, a color filter, tint, pigment, dye, resonant guided-mode filter, a rugate filter, or any combination thereof. 5. The apparatus of claim 1 , wherein the value of T melan is 0.33, the value of Trec,590 is 0.33, and the value of T grn is 0.5. 6. The apparatus of claim 1 , wherein the value of T melan is 0.25, the value of T rec,590 is 0.25, and the value of T grn is 0.5. 7. The apparatus of claim 1 , wherein the filter has chromaticity coordinates of x=0.355 and y=0.348. 8. An apparatus for reducing the frequency and/or severity of photophobic responses or for modulating circadian cycles by controlling exposure of cells in a retina, relative to a visible spectrum range of 400 nm to 700 nm, the apparatus comprising: an optical filter configured with: a light transmission fraction, averaged across wavelengths between about 454 nm and about 506 nm, with a value less than an amount T melan ; a light transmission fraction, averaged across wavelengths between about 565 nm and about 615 nm, with a value less than an amount T rec,590 ; and a light transmission fraction, averaged across wavelengths within a visible spectrum between 506 nm and 565 nm, with a value greater than an amount T grn ; wherein a first ratio including said light transmission fractions is defined as a first figure of merit (FOM 1 ), the first figure of merit being determined by: FOM 1 = 1 - T melan 1 - T grn wherein the first figure of merit of said optical filter is at least 1.3, wherein a second ratio including said light transmission fractions is defined as a second figure of merit (FOM 2 ), the second figure of merit being determined by: FOM 2 = 1 - T rec , 5 9
having spectral characteristics for purposes other than sun-protection · CPC title
by the sight sense · CPC title
Filters · CPC title
Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis · CPC title
Rugate filters · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.